🔬 Exciting News in Clinical Research! ⚖️ I am thrilled to share that I have rejoined my colleagues at the UNC Institute for Global Health & Infectious Diseases to administer the World Health Organization's Composite International Diagnostic Interview (CIDI) for The National Institutes of Health -funded studies. Our focus is the Study of Treatment and Reproductive Outcomes in Women (STAR) cohort, which aims to understand the effects of HIV infection and HIV-related medical conditions on women of reproductive age. The STAR cohort builds on the foundational work of the UNC-WOMEN'S INTERAGENCY HIV STUDY (WIHS), initiated in 1993. WIHS is one of the largest federally funded longitudinal cohort studies, encompassing nearly 4,000 women living with HIV (WLWH) or at risk for HIV infection. Recently, WIHS combined with the Multicenter AIDS Cohort Study (MACS), a cohort of gay and bisexual men, to form the MACS/WIHS Combined Cohort Study (MWCCS). I am particularly excited about this opportunity as it allows me to honor one of my most admired leaders in HIV research, Ada Adimora, who recently passed away. Joining this team ensures that her impactful work continues with the same quality and compassion she exemplified. My 20+ years of professional commitment to addressing health disparities and promoting health equity through research, community partnership development, and health communication have been pivotal in my journey. I have successfully adapted and implemented interventions in diverse settings, expanded study sites to reach diversity recruitment targets, and secured significant funding to further our mission. Highlights of My Work: Diversity and Inclusion in Clinical Trials: Successfully expanded a breast cancer intervention to community clinics, achieving high satisfaction rates among participants. Health Equity Research: Evaluated a $70k CDC Foundation grant, securing an additional $100k in funding. Health Communication: Produced the podcast series, "Advancing Accurate Representation in Research," reaching a global audience and promoting diversity in clinical trials. Get Involved: Research opportunities are available at UNC-Chapel Hill, UNC Health, and across North Carolina through Research for Me. Whether you're interested in a clinical trial or a research study, there are numerous ways to participate and make a difference. Check out the website to learn more: https://lnkd.in/eGvR7Cte Current Study Recruiting: Women aged 18-45 who are sexually active may be eligible for a study with compensation up to $150 per visit and travel reimbursement. For more information, call or text (919) 338-3650. Together, let's drive meaningful change and promote diversity in clinical research! Thank you for your support and engagement. #DiversityInResearch #ClinicalTrials #HealthEquity #HIVResearch #PublicHealth #JoinTheResearch
Niasha Fray Consulting LLC’s Post
More Relevant Posts
-
📃Scientific paper: Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not Abstract: BACKGROUND: High antiretroviral therapy (ART) coverage and viral suppression among people with HIV (PWH) in Australia provide a unique context to study individual cognitive trajectories, cognitive aging and factors associated with longitudinal cognitive function during chronic and stable HIV disease. METHODS: Participants from the Predictors of Adherence to Antiretroviral Therapy study (n = 457, recruited between September 2013 and November 2015, median age = 52 years, and all with HIV RNA <50 copies mL) completed a cognitive assessment with CogState Computerized Battery (CCB) at baseline, Month-12, and Month-24. Demographics, psycho-social and socioeconomic factors, healthcare seeking behaviors, HIV disease characteristics and comorbidities were assessed. The CCB data were corrected for age, sex and practice effect and averaged into a global z-score (GZS). Cognitive impairment was defined with the global deficit score method (GDS>0.5). Meaningful cognitive change was statistically defined (decline or improvement versus stability, i.e., 90% CI, that is p < 0.05, 2-tailed) using a novel evidence-based change score: the linear mixed-effect regression (LMER)-based GZS change score. A separate LMER model with a top-down variable selection approach identified the independent effects of age and other demographic, HIV disease characteristics, socioeconomic and health-related factors on the demographically corrected GZS. The combined definitions of change and cross-sectional... Continued on ES/IODE ➡️ https://etcse.fr/J8 ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.
To view or add a comment, sign in
-
📃Scientific paper: Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not Abstract: BACKGROUND: High antiretroviral therapy (ART) coverage and viral suppression among people with HIV (PWH) in Australia provide a unique context to study individual cognitive trajectories, cognitive aging and factors associated with longitudinal cognitive function during chronic and stable HIV disease. METHODS: Participants from the Predictors of Adherence to Antiretroviral Therapy study (n = 457, recruited between September 2013 and November 2015, median age = 52 years, and all with HIV RNA <50 copies mL) completed a cognitive assessment with CogState Computerized Battery (CCB) at baseline, Month-12, and Month-24. Demographics, psycho-social and socioeconomic factors, healthcare seeking behaviors, HIV disease characteristics and comorbidities were assessed. The CCB data were corrected for age, sex and practice effect and averaged into a global z-score (GZS). Cognitive impairment was defined with the global deficit score method (GDS>0.5). Meaningful cognitive change was statistically defined (decline or improvement versus stability, i.e., 90% CI, that is p < 0.05, 2-tailed) using a novel evidence-based change score: the linear mixed-effect regression (LMER)-based GZS change score. A separate LMER model with a top-down variable selection approach identified the independent effects of age and other demographic, HIV disease characteristics, socioeconomic and health-related factors on the demographically corrected GZS. The combined definitions of change and cross-sectional... Continued on ES/IODE ➡️ https://etcse.fr/J8 ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.
Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not
ethicseido.com
To view or add a comment, sign in
-
📃Scientific paper: Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria Abstract: Background High HIV prevalence, and lack of organized screening for the indigent population receiving care and treatment within HIV clinics in low-resource settings increases cervical cancer incidence. We sought to determine predictors of cervical precancer in women living with HIV and receiving cervical cancer screening in Jos, Nigeria. Methods A cross-sectional study of women living with HIV and receiving care and treatment in adult HIV/AIDS clinics in Jos-Metropolis, Nigeria between June 2020 and April 2023. Ethical approvals were obtained from the ethics committee in Jos, Nigeria and Northwestern University IRB, USA. Informed consent was obtained from eligible participants, and data on socio-demographics, cancer risk factors, and cytology reports were collected. The outcome variables were cervical precancer lesions. The independent variables were prior Pap smear status, socio-demographics, income, educational, and other reproductive health factors. Descriptive statistics was done to obtain means ± sd, frequencies, and percentages for the variables. Univariate and bivariate analyses were done to determine predictors of cervical dysplasia. Analyses were performed using R software. Results Of 957 women screened, 570 were living with HIV and 566 women had cytology report and were included in the final analysis. The mean age was 45.08 ± 8.89 years and 81.6% had no prior evidence of Pap test (under-screened). Prevalence of cervical dysplasia was 24% (mild and seve... Continued on ES/IODE ➡️ https://etcse.fr/fWb ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.
Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria
ethicseido.com
To view or add a comment, sign in
-
📃Scientific paper: Electronic medical record-based prediction models developed and deployed in the HIV care continuum: a systematic review Abstract: Objective To assess the methodological issues in prediction models developed using electronic medical records (EMR) and their early-stage clinical impact on the HIV care continuum. Methods A systematic search of entries in PubMed and Google Scholar was conducted between January 1, 2010, and January 17, 2022, to identify studies developing and deploying EMR-based prediction models. We used the CHARMS (Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies), PROBAST (Prediction Model Risk of Bias Assessment Tool), and TRIPOD (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis) statements to assess the methodological issues. In addition, we consulted reporting guidelines for early-stage clinical evaluation of decision support systems to assess the clinical impact of the models. Results The systematic search yielded 35 eligible articles: 24 (68.6%) aimed at model development and 11 (31.4%) for model deployment. The majority of these studies predicted an individual's risk of carrying HIV (n = 12/35, 34.3%), the risk of interrupting HIV care (n = 9/35), and the risk of virological failure (n = 7/35). The methodological assessment for those 24 studies found that they were rated as high risk (n = 6/24), some concerns (n = 14/24), and a low risk of bias (n = 4/24). Several studies didn't report the number of events (n = 14/24), missing data management (n = 12/24), inadequate reporting of statis... Continued on ES/IODE ➡️ https://etcse.fr/Tap ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.
Electronic medical record-based prediction models developed and deployed in the HIV care continuum: a systematic review
ethicseido.com
To view or add a comment, sign in
-
📃Scientific paper: Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria Abstract: Background High HIV prevalence, and lack of organized screening for the indigent population receiving care and treatment within HIV clinics in low-resource settings increases cervical cancer incidence. We sought to determine predictors of cervical precancer in women living with HIV and receiving cervical cancer screening in Jos, Nigeria. Methods A cross-sectional study of women living with HIV and receiving care and treatment in adult HIV/AIDS clinics in Jos-Metropolis, Nigeria between June 2020 and April 2023. Ethical approvals were obtained from the ethics committee in Jos, Nigeria and Northwestern University IRB, USA. Informed consent was obtained from eligible participants, and data on socio-demographics, cancer risk factors, and cytology reports were collected. The outcome variables were cervical precancer lesions. The independent variables were prior Pap smear status, socio-demographics, income, educational, and other reproductive health factors. Descriptive statistics was done to obtain means ± sd, frequencies, and percentages for the variables. Univariate and bivariate analyses were done to determine predictors of cervical dysplasia. Analyses were performed using R software. Results Of 957 women screened, 570 were living with HIV and 566 women had cytology report and were included in the final analysis. The mean age was 45.08 ± 8.89 years and 81.6% had no prior evidence of Pap test (under-screened). Prevalence of cervical dysplasia was 24% (mild and seve... Continued on ES/IODE ➡️ https://etcse.fr/fWb ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.
Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria
ethicseido.com
To view or add a comment, sign in
-
📃Scientific paper: Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria Abstract: BACKGROUND: High HIV prevalence, and lack of organized screening for the indigent population receiving care and treatment within HIV clinics in low-resource settings increases cervical cancer incidence. We sought to determine predictors of cervical precancer in women living with HIV and receiving cervical cancer screening in Jos, Nigeria. METHODS: A cross-sectional study of women living with HIV and receiving care and treatment in adult HIV/AIDS clinics in Jos-Metropolis, Nigeria between June 2020 and April 2023. Ethical approvals were obtained from the ethics committee in Jos, Nigeria and Northwestern University IRB, USA. Informed consent was obtained from eligible participants, and data on socio-demographics, cancer risk factors, and cytology reports were collected. The outcome variables were cervical precancer lesions. The independent variables were prior Pap smear status, socio-demographics, income, educational, and other reproductive health factors. Descriptive statistics was done to obtain means ± sd, frequencies, and percentages for the variables. Univariate and bivariate analyses were done to determine predictors of cervical dysplasia. Analyses were performed using R software. RESULTS: Of 957 women screened, 570 were living with HIV and 566 women had cytology report and were included in the final analysis. The mean age was 45.08 ± 8.89 years and 81.6% had no prior evidence of Pap test (under-screened). Prevalence of cervical dysplasia was 24% (mild and s... Continued on ES/IODE ➡️ https://etcse.fr/SAPDe ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.
Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria
ethicseido.com
To view or add a comment, sign in
-
📃Scientific paper: The impact of the COVID-19 pandemic on routine HIV care and cervical cancer screening in North-Central Nigeria Abstract: Introduction Cervical cancer is the fourth most diagnosed cancer among women globally, with much of the burden being carried by women in limited-resource settings often worsened by the high prevalence of HIV. Furthermore, the COVID-19 pandemic disrupted organized screening efforts and HIV management regimens worldwide, and the impact of these disruptions have not been examined in these settings. The purpose of this paper is to describe whether uptake of cervical cancer screening and HIV management changed before, during, and since the COVID-19 pandemic in North-Central Nigeria. Methods Longitudinal healthcare administration data for women who obtained care between January 2018 and December 2021 were abstracted from the AIDS Prevention Initiative Nigeria (APIN) clinic at Jos University Teaching Hospital. Patient demographics, pap smear outcomes, and HIV management indicators such as viral load and treatment regimen were abstracted and assessed using descriptive and regression analyses. All analyses were conducted comparing two years prior to the COVID-19 pandemic, the four quarters in 2020, and the year following COVID-19 restrictions. Results We included 2304 women in the study, most of whom were between 44 and 47 years of age, were married, and had completed secondary education. About 85% of women were treated with first line highly active retroviral therapy (HAART). Additionally, 84% of women screened using pap smear had normal results. The average age of women w... Continued on ES/IODE ➡️ https://etcse.fr/TSnq ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.
The impact of the COVID-19 pandemic on routine HIV care and cervical cancer screening in North-Central Nigeria
ethicseido.com
To view or add a comment, sign in
-
Request for Information (RFI) to inform development of the FY 2026-2030 NIH Strategic Plan for HIV and HIV-Related Research Through this Request for Information (RFI), the Office of AIDS Research (OAR) in the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), National Institutes of Health (NIH), invites feedback from researchers, health care professionals, advocates and health advocacy organizations, scientific or professional organizations, federal/state/local government agencies, community, and other interested constituents on the development of the fiscal year (FY) 2026-2030 NIH Strategic Plan for HIV and HIV-Related Research (the Plan). The Plan guides the NIH investment, building on scientific progress and opportunities for advancing HIV/AIDS research toward an end to the pandemic. ............... Information requested Respondents are invited to propose research priorities within each Goal as described below. This feedback will assist in informing the FY 2026-2030 Plan. Please note that response fields are limited to 200 words. Professional societies, advocacy organizations, and other groups are encouraged to submit a single collective response that reflects the views of their membership. ..........
NOT-OD-24-060
grants.nih.gov
To view or add a comment, sign in
-
📃Scientific paper: Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model Abstract: BACKGROUND: Women living with HIV are at increased risk of developing cervical cancer (CC). Screening for cancer is an important preventive strategy for the early detection of precancerous lesions and its management. There has been inadequate evidence on cervical cancer screening (CCS) practices among HIV-positive women in rural western Uganda. This study aimed to assess the prevalence and predictors of CCS among HIV-positive women, as well as knowledge and practices regarding cervical cancer screening. METHODS: A cross-sectional, analytical study was conducted among HIV-positive women attending HIV care facilities located in rural settings of western Uganda. A validated and interview-based data collection form was used to capture statistics regarding demographics, HIV care, obstetric profile, health belief constructs, and knowledge and history of CCS from the participants. Bivariate and multivariate logistic regression analyses were used to correlate women’s characteristics and health beliefs toward CCS practices. RESULTS: The prevalence of CCS among HIV-positive women was found to be 39.1% (95%CI: 14.0–71.7). A multivariate logistic regression analysis showed that post-secondary education attainment (AOR = 3.21; 95%CI = 2.12–7.28), four years or more lapsing after being diagnosed as HIV-positive (AOR = 2.87; 95%CI = 1.34–6.13), having more than one child (AOR = 1.87; 95%CI = 1.04–3.35), antenatal care attendance (AOR = 1.74; 95%CI = 1.02–3.43), post-natal care att... Continued on ES/IODE ➡️ https://etcse.fr/7ET4 ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.
Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model
ethicseido.com
To view or add a comment, sign in
-
The elevated cardiovascular disease risk among people with HIV is even greater than predicted by a standard risk calculator in several groups, including Black people and cisgender women, according to analyses from a large international clinical trial primarily funded by the National institutes of Health and presented at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver. The risk of having a first major cardiovascular event was also higher than previously predicted for people from high-income regions and those whose HIV replication was not suppressed below detectable levels. The scientists compared the incidence of cardiovascular events in the trial to the incidence predicted by standard estimates, which use the American College of Cardiology and American Heart Association’s Pooled Cohort Risk Equations (PCE) score. They found that the rate of cardiovascular events occurring in many groups of people differed from predicted rates, even considering that people with HIV have a higher overall risk of cardiovascular disease than people without HIV, including double the risk of major adverse cardiovascular events. Notably, in high-income regions—as defined by the global burden of disease classification system—including North and South America and Europe, cardiovascular event rates were higher overall, with cisgender women experiencing about two and a half times more events than predicted, and Black participants having more than 50% higher event rates than predicted. A second, related analysis defined risk factors contributing to the occurrence of major adverse cardiovascular events, such as heart attacks and strokes, in people with HIV in the trial. Using an analysis that considers many varying factors at once, the study team assessed risk factors contributing to these events. They found that the risk of experiencing a first major adverse cardiovascular event was higher for people with HIV from high-income regions; older than 50 years; Black; current or former cigarette smokers; with hypertension or a family history of early cardiovascular disease onset; or with a detectable HIV viral load, the amount of HIV in the blood. Viral load is detectable when viral replication is not fully suppressed by HIV antiretroviral therapy. ➡️ https://lnkd.in/dfuqnsQh #hiv #cardiovascularrisk #cardiovascularhealth #cardiovasculardisease
Tools underestimate cardiovascular event risk in people with HIV
nih.gov
To view or add a comment, sign in
519 followers
Director, Service & Strategy Lead, Veeva Development Cloud CoE
2moGreat news, congrats!